![](/img/cover-not-exists.png)
Maintenance of clinical response and consistent safety profile with up to three years of continuous treatment with guselkumab: results from the VOYAGE 1 and VOYAGE 2 trials
Reich, Kristian, Griffiths, Christopher E.M., Gordon, Kenneth B., Papp, Kim A., Song, Michael, Randazzo, Bruce, Li, Shu, Shen, Yaung-Kaung, Han, Chenglong, Kimball, Alexa B., Armstrong, April W., FoleJournal:
Journal of the American Academy of Dermatology
DOI:
10.1016/j.jaad.2019.11.040
Date:
December, 2019
File:
PDF, 356 KB
2019